Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including Bentonville
This study is completed. It focuses on suicide prevention and currently lists study information in the United States.
In MinneapolisThis study is completed. It focuses on schizophrenia and currently lists study information in India.
Multiple locations, including AhmedabadThis study is completed in the United States, in France, in Canada, .... It focuses on depression.
Multiple locations, including BirminghamThis study is active but not recruiting. It focuses on depression and currently lists study information in the United States.
In Long BeachThis study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including Garden GroveThis study is active but not recruiting in the United States. It is testing ANAVEX3-71 for schizophrenia.
In MarltonThis study is completed in the United States, in France, in Brazil, .... It is testing aripiprazole (Abilify) for manic episodes in bipolarity.
Multiple locations, including TuscaloosaThis study was terminated in the United States, in Belgium, in Brazil, .... It is testing Aticaprant 10 mg for depression.
Multiple locations, including HuntsvilleThis study is completed in the United States, in France, in Canada, .... It is testing Aticaprant 10 Milligrams (mg) for Depression.
Multiple locations, including BirminghamThis study was terminated in the United States, in Australia, in France, .... It is testing aticaprant for depression.
Multiple locations, including BirminghamThis study was terminated in the United States, in France, in Belgium, .... It is testing aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms for depression.
Multiple locations, including Little RockHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.